Analysts expect HealthStream to report Q3 2026 revenue of $82.24 million and EPS of $0.16, while the stock currently trades at $33.80, slightly above the average analyst price target of $32.50.
Investors are primarily focused on the company's deliberate "investment ramp," which is expected to compress margins as HealthStream expands its career networks business and increases professional service costs.
Recent performance has been strong, with four consecutive quarters of accelerating revenue growth, but management has warned of a planned "pause" in profitability for the second half of 2026. Market participants will scrutinize whether underlying subscription growth remains intact following a one-time $2 million accounting catch-up that inflated second-quarter results.